Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.88 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.88 |
| ▸ | MEN1 | O00255 | 1/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.88 |
| ▸ | DGKA | P23743 | 1/20 | 0.74 |
| ▸ | FAAH | O00519 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 3/20 | 0.59 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.59 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.59 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.58 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.58 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.58 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.58 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.58 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.58 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Monoctanoin Component B SCHEMBL8394660 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Decanoic Acid SCHEMBL4663166 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glycerol Monolaurate SCHEMBL2241699 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Palmitic Acid SCHEMBL23850779 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1960888 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Monoctanoin Component A SCHEMBL25311832 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Nonadecanoic Acid SCHEMBL2028549 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Heptadecanoic Acid SCHEMBL2006352 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL365822 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL16684813 | 1.00 | LMNA (0.88) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116211742-A | Microemulsion and preparation method thereof | 上海林清轩生物科技有限公司 | 2023-06-06 | — | — | CN | claimed |
| WO-2018055641-A1 | ORAL MODIFIED RELEASE FORMULATIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2018-03-29 | — | — | WO | claimed |
| US-20170128379-A1 | MODIFIED RELEASE PHARMACEUTICAL PREPARATIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2017-05-11 | — | — | US | claimed |
| WO-2016001937-A2 | MODIFIED RELEASE PHARMACEUTICAL PREPARATIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2016-01-07 | — | — | WO | claimed |
| US-20120093738-A1 | TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2012-04-19 | — | — | US | claimed |
| WO-2011030351-A2 | TASTE - MASKED PHARMACEUTICAL COMPOSITIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2011-03-17 | — | — | WO | claimed |
| WO-2010143207-A1 | TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2010-12-16 | — | — | WO | claimed |
| WO-2010116385-A2 | PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING UNPLEASANT TASTE | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2010-10-14 | — | — | WO | claimed |
| WO-2010046933-A2 | PHARMACEUTICAL COMPOSITIONS OF TASTE-MASKED LINEZOLID | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2010-04-29 | — | — | WO | claimed |
| WO-2010044108-A2 | CONTROLLED RELEASE FORMULATIONS OF ROPINIROLE | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2010-04-22 | — | — | WO | claimed |
| WO-2009078034-A2 | ORAL DISINTEGRATING TABLETS OF ROPINIROLE HYDROCHLORIDE | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2009-06-25 | — | — | WO | claimed |
| US-5888533-A | Non-polymeric sustained release delivery system | ATRIX LABORATORIES, INC. (US) | 1999-03-30 | — | — | US | claimed |
| US-12576017-B2 | Sunscreen composition with enhanced photoprotection | EDGEWELL PERSONAL CARE BRANDS, LLC (US) | 2026-03-17 | — | — | US | disclosed |
| US-12546710-B2 | Detection of a personal care composition based on infrared radiation | EDGEWELL PERSONAL CARE BRANDS, LLC (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250367107-A1 | SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT | EDGEWELL PERSONAL CARE BRANDS LLC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4647131-A2 | PERSONAL CARE COMPOSITION AND PERSONAL CARE PRODUCT | Edgewell Personal Care Brands, LLC (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-0140921-A1 | PHARMACEUTICAL COMPOSITIONS. | BLOCH MAURICE | 1985-05-15 | — | — | EP | disclosed |
| WO-1984003623-A1 | PHARMACEUTICAL COMPOSITIONS | BLOCH MAURICE | 1984-09-27 | — | — | WO | disclosed |
| US-4434153-A | Drug delivery system comprising a reservoir containing a plurality of tiny pills | ALZA CORPORATION (US) | 1984-02-28 | — | — | US | disclosed |
| US-4104370-A | Method of treating magnesium/potassium depletion | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546710-B2 | Detection of a personal care composition based on infrared radiation | DDR1, XPA, ERCC1 | LMNA 1935/4885KDM4E 2884/4885DUSP3 2541/4885 |
| US-12576017-B2 | Sunscreen composition with enhanced photoprotection | TELO2, AS3MT, TYR | LMNA 3703/4885KDM4E 1010/4885DUSP3 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.